IUPAC/Chemical Name
2-Butenamide, N-(1-((dimethylamino)carbonyl)propyl)-N-propyl-
InChi Key
CYZWCBZIBJLKCV-RMKNXTFCSA-N
InChi Code
InChI=1S/C13H24N2O2/c1-6-9-12(16)15(10-7-2)11(8-3)13(17)14(4)5/h6,9,11H,7-8,10H2,1-5H3/b9-6+
SMILES Code
C/C=C/C(N(C(C(N(C)C)=O)CC)CCC)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
240.35
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Sams RA, Gerken DF, Ashcraft SM. Pharmacokinetics of intravenous and oral prethcamide in horses. J Pharm Biomed Anal. 1997 Feb;15(5):639-51. doi: 10.1016/s0731-7085(96)01885-7. PMID: 9127276.
2: Strano-Rossi S, Colamonici C, Botrè F. Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis. Anal Chim Acta. 2008 Jan 14;606(2):217-22. doi: 10.1016/j.aca.2007.10.053. Epub 2007 Nov 9. PMID: 18082653.
3: Bleul U, Bylang T. Effects of doxapram, prethcamide and lobeline on spirometric, blood gas and acid-base variables in healthy new-born calves. Vet J. 2012 Nov;194(2):240-6. doi: 10.1016/j.tvjl.2012.04.007. Epub 2012 May 18. PMID: 22609153.
4: Babbini M, Gaiardi M, Bartoletti M. Some behavioral effects of prethcamide compared with those of its two components. Pharmacology. 1976;14(5):455-63. doi: 10.1159/000136628. PMID: 1036337.
5: Vanacore N, Binazzi A, Bottazzi M, Belli S. Amyotrophic lateral sclerosis in an Italian professional soccer player. Parkinsonism Relat Disord. 2006 Jun;12(5):327-9. doi: 10.1016/j.parkreldis.2005.11.007. Epub 2006 Feb 3. PMID: 16459125.
6: Delbeke FT, Debackere M, Jonckheere JA, De Leenheer AP. Characterization of two metabolites of prethcamide by gas chromatography and mass spectrometry. Biopharm Drug Dispos. 1986 Jul-Aug;7(4):389-96. doi: 10.1002/bdd.2510070408. PMID: 3768493.
7: Lu J, Wang S, Dong Y, Wang X, Yang S, Zhang J, Deng J, Qin Y, Xu Y, Wu M, Ouyang G. Simultaneous analysis of fourteen tertiary amine stimulants in human urine for doping control purposes by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry. Anal Chim Acta. 2010 Jan 4;657(1):45-52. doi: 10.1016/j.aca.2009.10.016. Epub 2009 Oct 27. PMID: 19951756.
8: Bryła P, Szumiło T. Pharmacokinetics of prethcamide following rapid intravenous injection and oral administration in rabbits. Pol J Pharmacol Pharm. 1985 Sep-Oct;37(5):653-61. PMID: 3832011.
